Antiparanodal antibodies in CIDP.
Since 2013, a number of new antibodies to nodal and paranodal antigens have been identified in a small proportion of patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
Anti neurofascin 155 antibodies have been found in patients sharing a phenotype consisting of distal weakness, tremor and ataxia as well as immunoglobulin resistance.
Please continue here.
